Heat Biologics IPO
Heat Biologics CEO Jeff Wolf (center) is surrounded by investors, board members, employees and supporters as he rings the closing bell on the NASDAQ after Heat's $25M IPO. Wolf is flanked by his wife and daughter on his left and, on his right, Eckhard Podack, M.D., Ph.D., inventor of Heat's proprietary anti-cancer technology platform. (Photo courtesy of NASDAQ)Copyright 2013 WRAL Tech Wire. All rights reserved.